全文获取类型
收费全文 | 22813篇 |
免费 | 2108篇 |
国内免费 | 10篇 |
出版年
2023年 | 135篇 |
2022年 | 298篇 |
2021年 | 581篇 |
2020年 | 341篇 |
2019年 | 443篇 |
2018年 | 507篇 |
2017年 | 395篇 |
2016年 | 751篇 |
2015年 | 1181篇 |
2014年 | 1295篇 |
2013年 | 1526篇 |
2012年 | 1861篇 |
2011年 | 1639篇 |
2010年 | 1070篇 |
2009年 | 912篇 |
2008年 | 1219篇 |
2007年 | 1195篇 |
2006年 | 1096篇 |
2005年 | 997篇 |
2004年 | 957篇 |
2003年 | 796篇 |
2002年 | 802篇 |
2001年 | 303篇 |
2000年 | 284篇 |
1999年 | 275篇 |
1998年 | 206篇 |
1997年 | 200篇 |
1996年 | 191篇 |
1995年 | 151篇 |
1994年 | 149篇 |
1993年 | 137篇 |
1992年 | 166篇 |
1991年 | 151篇 |
1990年 | 181篇 |
1989年 | 171篇 |
1988年 | 142篇 |
1987年 | 138篇 |
1986年 | 117篇 |
1985年 | 151篇 |
1984年 | 120篇 |
1983年 | 94篇 |
1982年 | 99篇 |
1981年 | 87篇 |
1980年 | 97篇 |
1979年 | 104篇 |
1978年 | 85篇 |
1976年 | 93篇 |
1974年 | 86篇 |
1973年 | 82篇 |
1972年 | 84篇 |
排序方式: 共有10000条查询结果,搜索用时 984 毫秒
21.
22.
Emily Olfson Catherine E. Cottrell Nicholas O. Davidson Christina A. Gurnett Jonathan W. Heusel Nathan O. Stitziel Li-Shiun Chen Sarah Hartz Rakesh Nagarajan Nancy L. Saccone Laura J. Bierut 《PloS one》2015,10(9)
The American College of Medical Genetics and Genomics (ACMG) recommends that clinical sequencing laboratories return secondary findings in 56 genes associated with medically actionable conditions. Our goal was to apply a systematic, stringent approach consistent with clinical standards to estimate the prevalence of pathogenic variants associated with such conditions using a diverse sequencing reference sample. Candidate variants in the 56 ACMG genes were selected from Phase 1 of the 1000 Genomes dataset, which contains sequencing information on 1,092 unrelated individuals from across the world. These variants were filtered using the Human Gene Mutation Database (HGMD) Professional version and defined parameters, appraised through literature review, and examined by a clinical laboratory specialist and expert physician. Over 70,000 genetic variants were extracted from the 56 genes, and filtering identified 237 variants annotated as disease causing by HGMD Professional. Literature review and expert evaluation determined that 7 of these variants were pathogenic or likely pathogenic. Furthermore, 5 additional truncating variants not listed as disease causing in HGMD Professional were identified as likely pathogenic. These 12 secondary findings are associated with diseases that could inform medical follow-up, including cancer predisposition syndromes, cardiac conditions, and familial hypercholesterolemia. The majority of the identified medically actionable findings were in individuals from the European (5/379) and Americas (4/181) ancestry groups, with fewer findings in Asian (2/286) and African (1/246) ancestry groups. Our results suggest that medically relevant secondary findings can be identified in approximately 1% (12/1092) of individuals in a diverse reference sample. As clinical sequencing laboratories continue to implement the ACMG recommendations, our results highlight that at least a small number of potentially important secondary findings can be selected for return. Our results also confirm that understudied populations will not reap proportionate benefits of genomic medicine, highlighting the need for continued research efforts on genetic diseases in these populations. 相似文献
23.
Riccardo E. Marioni Lars Penke Gail Davies Jennifer E. Huffman Caroline Hayward Ian J. Deary 《Proceedings. Biological sciences / The Royal Society》2014,281(1781)
Human cognitive ability shows consistent, positive associations with fitness components across the life-course. Underlying genetic variation should therefore be depleted by selection, which is not observed. Genetic variation in general cognitive ability (intelligence) could be maintained by a mutation–selection balance, with rare variants contributing to its genetic architecture. This study examines the association between the total number of rare stop-gain/loss, splice and missense exonic variants and cognitive ability in childhood and old age in the same individuals. Exome array data were obtained in the Lothian Birth Cohorts of 1921 and 1936 (combined N = 1596). General cognitive ability was assessed at age 11 years and in late life (79 and 70 years, respectively) and was modelled against the total number of stop-gain/loss, splice, and missense exonic variants, with minor allele frequency less than or equal to 0.01, using linear regression adjusted for age and sex. In both cohorts and in both the childhood and late-life models, there were no significant associations between rare variant burden in the exome and cognitive ability that survived correction for multiple testing. Contrary to our a priori hypothesis, we observed no evidence for an association between the total number of rare exonic variants and either childhood cognitive ability or late-life cognitive ability. 相似文献
24.
25.
26.
Ante M. Krstulovi Laura Bertani-Dziedzic Sandra Bautista-Cerqueira Stanley E. Gitlow 《Journal of chromatography. B, Analytical technologies in the biomedical and life sciences》1982,227(2):379-389
We describe a direct analysis for the simultaneous quantitative determination of 4-hydroxy-3-methoxyphenylacetic (homovanillic) acid and other monoamine metabolites in human lumbar cerebrospinal fluid, utilizing reversed-phase high-performance liquid chromatography with amperometric detection. In addition, a rapid isocratic separation was developed for homovanillic acid in the presence of other endogenous compounds.Twenty-five unselected diagnostic specimens of human lumbar cerebrospinal fluid were extracted with ethyl acetate and subsequently analyzed using the described method. Chromatographic peaks were identified on the basis of retention behavior and ratio of responses at several oxidation potentials.Although our quantitative results correlate well with the literature values, the data were not interpreted clinically since samples were obtained from routine, diagnostic testing of patients admitted to the medical or neurologic services at the Mount Sinai Hospital. 相似文献
27.
The diminished production of arachidonic acid oxygenation products by elicited mouse peritoneal macrophages: possible mechanisms 总被引:12,自引:0,他引:12
28.
29.
R J Davies 《BMJ (Clinical research ed.)》1972,3(5826):564-565